We seek to establish a Diabetes and Endocrinology Research Center at Columbia University. The DERC will promote interactions among research groups in diabetes, immunology, transplantation and obesity at the Naomi Berrie Diabetes Center, The New York Obesity Research Center, and the historically strong groups in arteriosclerosis/lipid research at Columbia University. We envision that these interactions will extend to groups currently pursuing basic research in structural biology, genomics, complications, cell biology and clinical investigators in the areas of body composition, energy expenditure, genetic epidemiology of type 2 diabetes in adolescents, islet transplantation and prevention of diabetes complications. The DERC will strengthen existing NIH training grants in Endocrinology, Metabolism, Pediatrics, Arterioeclerosis, Immunology, Genetics and Obesity by broadening the pool of mentors and laboratories for the trainees' benefit. To meet these goals, the DERC will provide core services in six areas of research: Hormone/metabolite, Protein expression, Immunology/cell banking, Genomics, Analytical determinations of body composition and tissue metabolites, and Mouse phenotyping. Additionally, the DERC will provide opportunity and encouragement for established scientists in other research areas at Columbia University to enter the diabetes field, and will make available initial funding for young investigators through a pilot/feasibility grant program modeled after the existing Naomi Berrie Fellowship Award. The DERC will broaden the research base through program enrichment activities aimed at increasing the awareness of diabetes research in the scientific/academic community of Columbia University and New York City and through more extensive interactions with other academic institutions in the greater New York area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK063608-01
Application #
6577556
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Program Officer
Abraham, Kristin M
Project Start
2003-05-01
Project End
2008-01-31
Budget Start
2003-05-01
Budget End
2004-01-31
Support Year
1
Fiscal Year
2003
Total Cost
$1,344,099
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Tamucci, Kirstin A; Namwanje, Maria; Fan, Lihong et al. (2018) The dark side of browning. Protein Cell 9:152-163
Accili, Domenico (2018) Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes 67:1701-1709
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Shah, Ankit; Levesque, Kiarra; Pierini, Esmeralda et al. (2018) Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 20:1018-1023
Haeusler, Rebecca A; McGraw, Timothy E; Accili, Domenico (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31-44

Showing the most recent 10 out of 225 publications